Sponsor or institution
Clinical trials and research at Kiora Pharmaceuticals, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Kiora Pharmaceuticals, Inc. that are recruiting, in Australia. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Evaluating KIO-104 for treating macular edema
This study is testing a new treatment called KIO-104 to see if it can safely help people with macular edema improve their vision.
-
Intravitreal KIO-301 for people with late-stage retinitis pigmentosa
This trial will test whether injections of KIO-301 into both eyes are safe and can improve vision or light perception in adults with late-stage retinitis pigmentosa.
Quick answers
How many clinical trials run by Kiora Pharmaceuticals, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Australia. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.